{"title": "Epidemiological Development of Novel Coronavirus Pneumonia in China and Its Forecast", "doi": "10.1101/2020.02.21.20026229", "citation_id": "2020.02.21.20026229v1", "date": "2020-02-26", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.21.20026229", "abstract": "<p>ABSTRACT \nBACKGROUND AND OBJECTIVE\nThe novel coronavirus (SARS-Cov-2) infected coronavirus disease 2019 (COVID-19) was broken out in Wuhan and Hubei province for more than a month. It severely threats people9s health of thousands in Chin and even other countries. In order to prevent its wide spread, it is necessary to understand the development of the epidemic with precise mathematical language. \nMETHODS\n   The various data of novel coronavirus pneumonia were collected from the official websites of the National Health Committee of the People9s Republic of China. According to epidemic and administrative division, three groups were divided to analyze the data, Hubei Province (including Wuhan), nationwide without Hubei and Henan Province. With classic SIR models, the fitting epidemiological curves of incidence have made, and basic reproduction number (R0) was also calculated as well. Therefore the disease9s infection intensity, peak time and the epidemiological end time can be deduced.</p>", "twitter_description": "ABSTRACT BACKGROUND AND OBJECTIVE The novel coronavirus (SARS-Cov-2) infected coronavirus disease 2019 (COVID-19) was broken out in Wuhan and Hubei province for more than a month. It severely threats people's health of thousands in Chin and even other countries. In order to prevent its wide spread, it is necessary to understand the development of the epidemic with precise mathematical language. METHODS The various data of novel coronavirus pneumonia were collected from the official websites of the National Health Committee of the People's Republic of China. According to epidemic and administrative division, three groups were divided to analyze the data, Hubei Province (including Wuhan), nationwide without Hubei and Henan Province. With classic SIR models, the fitting epidemiological curves of incidence have made, and basic reproduction number (R0) was also calculated as well. Therefore the disease's infection intensity, peak time and the epidemiological end time can be deduced.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nFunding:This study was supported by Scientific and Technical Project of Henan Science and Technology Department (192102310134), Open Project of National Health Commission Key Laboratory of Birth Defect Prevention (ZD201903) and Medical Foundation of Health and Family Planning Commission of Henan Province (No. 2018020589)\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nDissemination to participants and related patient and public communities: No study participants were involved in the preparation of this article, which permits others to distribute, adapt and build upon this article noncommercially.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.21.20026229v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.21.20026229v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.21.20026229v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/26/2020.02.21.20026229.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.21.20026229v1", "access_rights": "restricted", "authors": ["Shan shan Wu", "Pan pan Sun", "Rui ling Li", "Liang Zhao", "Yan li Wang", "Li fang Jiang", "Jin Bo Deng"]}